Intestinal barrier and goblet cell function

The intestinal barrier and goblet cell function constitute a multi-layered defense system that maintains gut homeostasis by separating the luminal contents from the host's internal environment (PMID: 28588585). Goblet cells are specialized epithelial cells responsible for the synthesis and secretion of gel-forming mucins, primarily Mucin-2 (MUC2), which form the protective mucus layer that prevents pathogen contact with the epithelium (PMID: 22427236). Beyond the mucus layer, the physical barrier is maintained by tight junction proteins, such as claudins and occludin, which regulate paracellular permeability (PMC4676319). This system also involves the secretion of antimicrobial peptides and trefoil factors that facilitate mucosal repair and immune exclusion. Dysfunction in these components is strongly linked to the pathogenesis of inflammatory bowel disease (IBD) and celiac disease, where increased permeability allows for the translocation of pro-inflammatory antigens (PMID: 31076401). Chronic impairment of the intestinal barrier, often termed "leaky gut," can lead to systemic inflammation and is implicated in metabolic and autoimmune disorders. Therapeutic interventions, such as the GLP-2 analog Teduglutide, aim to enhance barrier function by promoting epithelial growth and repair (PMID: 26075903). Other experimental agents, like Larazotide acetate, target tight junction regulation to restore barrier integrity in conditions like celiac disease. Monitoring this system often involves measuring biomarkers like fecal calprotectin or serum zonulin to assess inflammation and permeability. Overall, maintaining the integrity of the intestinal barrier and the health of the goblet cell population is a critical therapeutic goal in gastroenterology.

Other names

Gut barrier functionIntestinal mucosal barrierGoblet cell homeostasisIntestinal epithelial barrier

Glucagon-like peptide 2 receptor (GLP2R) agonism to promote mucosal growth; Zonulin antagonism to stabilize tight junctions; Stimulation of prostaglandin synthesis to increase mucus secretion.